Nearly a third of all Indian factories that make active pharmaceutical ingredients are located in areas that were recently placed under pandemic-forced lockdowns, and many workers have fallen ill. Illustration: Brian Wang
India’s medicine makers in logistical ‘mess’ as coronavirus crisis disrupts pharmaceutical supply chain
- World’s largest provider of generic drugs is seeing its pharmaceutical companies stagger shifts as factory workers fall ill and supplies from China are delayed
- Nearly a third of Indian factories that make active pharmaceutical ingredients are located in areas that were recently placed under pandemic-forced lockdowns
Nearly a third of all Indian factories that make active pharmaceutical ingredients are located in areas that were recently placed under pandemic-forced lockdowns, and many workers have fallen ill. Illustration: Brian Wang
